FIG. 2.

A 51-year-old female presented with moderate (1/2 disc area) neovascularization elsewhere (NVE) and vitreous hemorrhage (VH) in the left eye, and fluorescein angiography (FA) showed large regions of NVE leakage compatible with the diagnosis of high-risk proliferative diabetic retinopathy. She received the first intravitreal injection of bevacizumab at baseline. After 1 month, VH remarkably cleared, and visual acuity improved from counting fingers (CF) at baseline to 20/40. Three months after bevacizumab injection, VH completely cleared up and FA disclosed no more fluorescein leakage from NVE. After 6 months, NVE completely regressed with fibrous tissue left. Color images available online at www.liebertpub.com/jop